Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis – The Lancet Global Health Invited Commentary: COVID-19 serosurveys for public health decision making – The Lancet Global Health Commentary on Twitter (thread – click for more) Now out: our systematic review and meta-analysis on seroprevalence surveys for SARS-CoV-2 is now out […]
The post M-A: Serological evidence of human infection with SARS-CoV-2 appeared first on Links Medicus.
Neutralizing Activity of BNT162b2-Elicited Serum – New England Journal of Medicine Commentaries: Expert reaction to NEJM correspondence paper looking at the neutralising activity of the Pfizer-BioNTech vaccine against SARS-CoV-2 variants in the lab – Science Media Centre AND Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study – Reuters
The post Lab study shows Pfizer/BioNTech COVID-19 vaccine can also neutralize B.1.351, P1 and B.1.1.7 variants appeared first on Links Medicus.
Recommendation Statement: Screening for Lung Cancer – US Preventive Services Task Force Editorials: Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity – JAMA AND Expanded Access to Lung Cancer Screening—Implementing Wisely to Optimize Health – JAMA Network Open AND New USPSTF Guidelines for Lung Cancer Screening: Better but Not Enough […]
The post USPSTF Statement: begin screening for lung cancer at age 50 years instead of 55 years for patients at risk appeared first on Links Medicus.
Restricting Daily Chest Radiography in the Intensive Care Unit: Implementing Evidence-Based Medicine to Decrease Utilization – Journal of the American College of Radiology Commentary: Curbing daily use of chest x-ray in ICU cuts major costs – AuntMinnie (free registration required) Commentary on Twitter "Changing ordering practices in the adult ICUs to align with established […]
The post Restricting daily chest radiography in the ICU: Implementing evidence-based medicine to decrease utilization appeared first on Links Medicus.
Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics (free for a limited period) Editorial: Rightsizing Treatment for Pneumonia in Children Commentary: Five days of antibiotics fine for children with pneumonia – McMaster University Commentary on Twitter (thread – click for more) This is fantastic! In outpatient community […]
The post RCT: 5 days of high-dose amoxicillin therapy noninferior to 10 days for the treatment of pediatric community-acquired pneumonia appeared first on Links Medicus.
SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection – medRxiv Commentary: How can physicians distinguish between COVID-19 persistence and SARS-CoV-2 reinfection? – News Medical
The post [Preprint] Systematic review: Characteristics of SARS-CoV-2 reinfection vs. persistent COVID-19 appeared first on Links Medicus.
Ten things to consider when implementing rationing guidelines during a pandemic – Intensive Care Medicine Commentary on Twitter Rationing in #pandemic? Consider1⃣identify scarce resources2⃣exhaust ways to integrate3⃣be clear/involve public4⃣prognosis/age5⃣responsibilities6⃣pt goals/choice7⃣disabilities, poverty, racism8⃣prioritize9⃣legal coverage?impact on HCWs#COVID19 https://t.co/iSWVbqH3FY pic.twitter.com/bIoYmsSKQD — Intens Care Med (@yourICM) March 7, 2021
The post Ten things to consider when implementing rationing guidelines during a pandemic appeared first on Links Medicus.
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England – Science Commentary: Study confirms B.1.1.7 variant of SARS-CoV-2 is more transmissible – News Medical Commentary on Twitter (thread – click for more) Our paper “Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England” has now been published in Science (early release: https://t.co/8LRLp669LL). […]
The post Study confirms higher transmissibility of SARS-CoV-2 lineage B.1.1.7 appeared first on Links Medicus.
News release: New Study of Coronavirus Variants Predicts Virus Evolving to Escape Current Vaccines, Treatments – Columbia University Irving Medical Center Original study: Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 – Nature Commentary on Twitter The B.1.351 and B.1.1.7 SARS-CoV-2 variants (first detected in South Africa and the UK, respectively) show increased resistance […]
The post New study of Coronavirus variants predicts virus evolving to escape current vaccines, treatments appeared first on Links Medicus.
Colchicine and COVID-19: a Tale of Two Trials – CVCT CardioBrief Study 1: RECOVERY trial: Colchicine arm stopped for lack of efficacy in patients hospitalized with COVID-19 Study 2: [Preprint] Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
The post Colchicine and COVID-19: a Tale of Two Trials appeared first on Links Medicus.